Astellas Pharma (ALPMY) Q2 2024 Earnings

25AprConfirmed
Q3 2023
Q4 2023
Q1 2024
Q2 2024
-0.12
-0.01
0.11
0.22

Details

Expected EPS
-0.019080844218
Actual EPS
-0.122583278422
Surprise EPS
-0.1
Surprise Percent
+542.44%

Description

Astellas Pharma (ALPMY) has reported earnings of -0.122583278422 per share for Q2 2024.

0 Comments

Share your thoughts